Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of substantially exceeding the current standard of care in the future, DeepView® is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView®, visit www.spectral-ai.com.
Company profile
Ticker
MDAI
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Rosecliff Acquisition Corp I
SEC CIK
Corporate docs
Subsidiaries
Spectral MD, Inc. • Spectral MD Holdings LLC • Spectral MD UK Limited • Spectral Deepview Limited ...
MDAI stock data
Latest filings (excl ownership)
424B3
Prospectus supplement
23 Apr 24
424B3
Prospectus supplement
23 Apr 24
424B3
Prospectus supplement
19 Apr 24
EFFECT
Notice of effectiveness
19 Apr 24
S-1
IPO registration
10 Apr 24
DEFA14A
Additional proxy soliciting materials
4 Apr 24
DEF 14A
Definitive proxy
4 Apr 24
8-K
Departure of Directors or Certain Officers
2 Apr 24
8-K
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
1 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
Transcripts
Latest ownership filings
SC 13G/A
HIRSCH LAURENCE E
19 Apr 24
SC 13D/A
DiMaio John Michael
27 Feb 24
SC 13D/A
SPANGENBERG ERICH
26 Feb 24
SC 13G
Octopus Investments Ltd.
8 Feb 24
4
John Michael DiMaio
22 Nov 23
4
Richard John Cotton
20 Nov 23
SC 13G
HIRSCH LAURENCE E
3 Nov 23
SC 13D
DiMaio John Michael
27 Oct 23
SC 13D/A
SPANGENBERG ERICH
26 Oct 23
SC 13D
SPANGENBERG ERICH
26 Sep 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.35 mm | 7.35 mm | 7.35 mm | 7.35 mm | 7.35 mm | 7.35 mm |
Cash burn (monthly) | (no burn) | 604.92 k | 3.56 mm | 58.19 k | 3.50 mm | 918.42 k |
Cash used (since last report) | n/a | 4.18 mm | 24.58 mm | 401.68 k | 24.14 mm | 6.34 mm |
Cash remaining | n/a | 3.17 mm | -17.23 mm | 6.95 mm | -16.79 mm | 1.01 mm |
Runway (months of cash) | n/a | 5.2 | -4.8 | 119.4 | -4.8 | 1.1 |
Institutional ownership, Q2 2023
54.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 39 |
Opened positions | 36 |
Closed positions | 3 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 2.47 bn |
Total shares | 9.53 mm |
Total puts | 0.00 |
Total calls | 185.76 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Rosecliff Acquisition Sponsor I | 6.20 mm | $0.00 |
Periscope Capital | 438.58 k | $26.32 mm |
Owl Creek Asset Management | 223.99 k | $13.44 mm |
Q Global Advisors | 211.79 k | $13.00 k |
Spartan Fund Management | 201.70 k | $12.30 mm |
Ionic Capital Management | 191.01 k | $11.46 mm |
Balyasny Asset Management | 190.32 k | $11.61 mm |
Bardin Hill Management Partners | 175.30 k | $10.00 k |
Susquehanna International | 161.09 k | $1.71 bn |
Kepos Capital | 149.43 k | $9.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Nov 23 | John Michael DiMaio | Common Stock, par value $0.0001 per share | Buy | Acquire P | Yes | No | 2.67 | 2,000 | 5.34 k | 2,481,908 |
17 Nov 23 | Richard John Cotton | Common Stock | Grant | Acquire A | No | No | 2.67 | 14,650 | 39.12 k | 47,529 |
16 Nov 23 | John Michael DiMaio | Common Stock, par value $0.0001 per share | Buy | Acquire P | Yes | No | 2.68 | 500 | 1.34 k | 2,479,908 |
14 Nov 23 | John Michael DiMaio | Common Stock, par value $0.0001 per share | Buy | Acquire P | Yes | No | 2.81 | 355 | 997.55 | 2,479,408 |
13 Sep 23 | John Michael DiMaio | Common Stock, par value $0.0001 per share | Buy | Acquire P | Yes | No | 5.07 | 198 | 1.00 k | 2,479,053 |
12 Sep 23 | John Michael DiMaio | Common Stock, par value $0.0001 per share | Buy | Acquire P | Yes | No | 5.97 | 1,000 | 5.97 k | 2,478,855 |
11 Sep 23 | Rosecliff Acquisition Sponsor I | Common Stock | Grant | Acquire A | No | No | 0 | 33,333 | 0.00 | 848,333 |
11 Sep 23 | Rosecliff Acquisition Sponsor I | Common Stock | Option exercise | Acquire M | No | No | 0 | 815,000 | 0.00 | 815,000 |
11 Sep 23 | Rosecliff Acquisition Sponsor I | Class B Common Stock Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 815,000 | 0.00 | 0 |
11 Sep 23 | Franklin S. Jr. Edmonds | Common Stock | Option exercise | Acquire M | No | No | 0 | 20,000 | 0.00 | 20,000 |
News
Spectral AI Q4 2023 GAAP EPS $(0.22) Beats $(0.40) Estimate, Sales $5.287M Beat $4.600M Estimate
27 Mar 24
Earnings Scheduled For March 27, 2024
27 Mar 24
Spectral AI Announces Receipt Of $1M Of Financing For Spectral IP, Inc., Its Intellectual Property Subsidiary Focused In The Broader Artificial Intelligence Ecosystem
19 Mar 24
Why Spectral AI Stock Is Climbing
12 Mar 24
Spectral AI Announces New U.S. Government Contract Valued At Over $500,000 To Further Accelerate The Development Of The Handheld Version Of DeepView Wound Imaging System
12 Mar 24
Press releases
Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call
24 Apr 24
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
24 Apr 24
Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results
27 Mar 24
Spectral AI Secures Access to $12.5 Million of New Equity Capital
20 Mar 24
Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
13 Mar 24